Brilacidin tetrahydrochloride
Cat. No.：YN250821
CAS No. ：1224095-99-1
| 产品名称: | Brilacidin tetrahydrochloride |
| CAS No.: | 1224095-99-1 |
| Chemical Name: | PMX 30063 Tetrahydrochloride; N4,N6-Bis[3-[[5-[(aminoiminomethyl)amino]-1-oxopentyl]amino]-2-[(3R)-3-pyrrolidinyloxy]-5-(trifluoromethyl)phenyl]-4,6-pyrimidinedicarboxamide Hydrochloride |
| Synonyms: | PMX 30063 tetrahydrochloride |
| 分子量: | 1082.75 |
| 分子式: | C₄₀H₅₄Cl₄F₆N₁₄O₆ |
| SMILES: | O=C(C1=NC=NC(C(NC2=CC(C(F)(F)F)=CC(NC(CCCCNC(N)=N)=O)=C2O[C@H]3CNCC3)=O)=C1)NC4=CC(C(F)(F)F)=CC(NC(CCCCNC(N)=N)=O)=C4O[C@H]5CNCC5.Cl.Cl.Cl.Cl |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Brilacidin tetrahydrochloride (PMX 30063 tetrahydrochloride) 是一种抗菌剂，对革兰氏阳性菌Streptococcus pneumonia和Streptococcus viridans的 MIC90 分别为 1 和 8 μg/mL，对革兰氏阴性菌Haemophilus influenza和Pseudomonas aeruginosa的 MIC90 分别为 8 和 4 μg/mL。Brilacidin tetrahydrochloride 是一种类似 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Scott, R.W.: Am. Biotech. Lab., 27, 16 (2009)
